Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. (September 2022)

Record Type:: Journal Article
Title:: Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. (September 2022)
Main Title:: Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
Authors:: Saxena, Amit
Engel, Alexis J
Banbury, Brittany
Hasan, Ghadeer
Fraser, Nicola
Zaminski, Devyn
Masson, Mala
Haberman, Rebecca H
Scher, Jose U
Ho, Gary
Law, Jammie
Rackoff, Paula
Tseng, Chung-E
Belmont, H Michael
Clancy, Robert M
Buyon, Jill P
Izmirly, Peter M
Abstract:
Is Part Of:: Lancet. Volume 4:Number 9(2022)
Journal:: Lancet
Issue:: Volume 4:Number 9(2022)
Issue Display:: Volume 4, Issue 9 (2022)
Year:: 2022
Volume:: 4
Issue:: 9
Issue Sort Value:: 2022-0004-0009-0000
Page Start:: e582
Page End:: e585
Publication Date:: 2022-09
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(22)00190-4 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23060.xml